STOCK TITAN

[Form 4] Biomea Fusion, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Rainer M. Erdtmann, a director and officer of Biomea Fusion (BMEA), reported multiple late-January 2025 stock transfers and a large option award. On 01/28/2025 he disposed of 40,000 shares and on 01/31/2025 recorded three additional disposals of 10,000 each alongside three indirect acquisitions of 10,000 shares attributed to his children, leaving 643,027 shares held directly following those transactions.

The filing discloses indirect holdings held in Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) and Point Sur Investors, LLC (252,320). It also reports a grant of 1,246,989 stock options on 08/11/2025 with a $1.53 exercise price, vesting in 16 quarterly installments beginning 08/08/2025 and fully vesting 08/08/2029, expiring 08/10/2035.

Rainer M. Erdtmann, direttore e dirigente di Biomea Fusion (BMEA), ha segnalato più trasferimenti di azioni alla fine di gennaio 2025 e una consistente assegnazione di opzioni. Il 01/28/2025 ha ceduto 40,000 azioni e il 01/31/2025 ha registrato tre ulteriori cessioni da 10,000 ciascuna insieme a tre acquisizioni indirette da 10,000 azioni attribuite ai suoi figli, mantenendo 643,027 azioni detenute direttamente dopo tali operazioni.

La comunicazione indica partecipazioni indirette in Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) e Point Sur Investors, LLC (252,320). Riporta inoltre l'assegnazione di 1,246,989 opzioni azionarie il 08/11/2025 con prezzo di esercizio di $1.53, che maturano in 16 tranche trimestrali a partire dal 08/08/2025, con piena maturazione il 08/08/2029 e scadenza il 08/10/2035.

Rainer M. Erdtmann, director y directivo de Biomea Fusion (BMEA), informó varias transferencias de acciones a finales de enero de 2025 y una importante concesión de opciones. El 01/28/2025 enajenó 40,000 acciones y el 01/31/2025 registró tres cesiones adicionales de 10,000 cada una junto con tres adquisiciones indirectas de 10,000 atribuidas a sus hijos, quedando con 643,027 acciones en propiedad directa tras esas operaciones.

El informe revela participaciones indirectas en Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) y Point Sur Investors, LLC (252,320). También informa la concesión de 1,246,989 opciones sobre acciones el 08/11/2025 con precio de ejercicio de $1.53, que se consolidan en 16 cuotas trimestrales a partir del 08/08/2025, con consolidación completa el 08/08/2029 y vencimiento el 08/10/2035.

Rainer M. Erdtmann은 Biomea Fusion(BMEA)의 이사이자 임원으로서 2025년 1월 말 여러 차례의 주식 이전과 대규모 스톡옵션 부여를 신고했습니다. 01/28/2025에 40,000주를 처분했으며 01/31/2025에는 각각 10,000주씩 세 건의 추가 처분과 자녀들에게 귀속된 간접 취득 10,000주 세 건을 기록해, 이들 거래 이후 직접 보유 주식은 643,027주입니다.

신고서에는 Trust 1(174,614), Trust 2(1,134,989), Point Sur Investors Fund I, LP(228,470) 및 Point Sur Investors, LLC(252,320)에 대한 간접 보유가 공개되어 있습니다. 또한 08/11/2025에 행사 가격 $1.531,246,989주의 스톡옵션이 부여되었으며, 이는 08/08/2025부터 16회 분기별 베스팅을 거쳐 08/08/2029에 완전히 베스팅되고 만료일은 08/10/2035입니다.

Rainer M. Erdtmann, directeur et cadre de Biomea Fusion (BMEA), a déclaré plusieurs transferts d'actions fin janvier 2025 ainsi qu'une importante attribution d'options. Le 01/28/2025 il a cédé 40,000 actions et le 01/31/2025 a enregistré trois cessions supplémentaires de 10,000 chacune, accompagnées de trois acquisitions indirectes de 10,000 actions attribuées à ses enfants, conservant 643,027 actions détenues directement après ces transactions.

Le dépôt fait état de participations indirectes détenues dans Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) et Point Sur Investors, LLC (252,320). Il signale également l'octroi de 1,246,989 options sur actions le 08/11/2025 au prix d'exercice de $1.53, se vestant en 16 tranches trimestrielles à partir du 08/08/2025, vesting complet le 08/08/2029 et expiration le 08/10/2035.

Rainer M. Erdtmann, ein Direktor und leitender Angestellter von Biomea Fusion (BMEA), meldete mehrere Aktienübertragungen Ende Januar 2025 sowie eine umfangreiche Optionszuteilung. Am 01/28/2025 veräußerte er 40,000 Aktien, und am 01/31/2025 wurden drei weitere Veräußerungen zu je 10,000 sowie drei indirekte Erwerbe zu je 10,000 Aktien, zugeschrieben seinen Kindern, verbucht; nach diesen Transaktionen hielt er direkt 643,027 Aktien.

Die Meldung nennt indirekte Bestände in Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) und Point Sur Investors, LLC (252,320). Ferner wird die Gewährung von 1,246,989 Aktienoptionen am 08/11/2025 mit einem Ausübungspreis von $1.53 berichtet, die in 16 vierteljährlichen Tranchen ab 08/08/2025 vesten, vollständig am 08/08/2029 vesten und am 08/10/2035 verfallen.

Positive
  • Substantial equity award: Grant of 1,246,989 stock options at a $1.53 exercise price with multi-year vesting aligns management incentives with shareholders.
  • Detailed indirect holdings disclosed: Footnotes list Trust 1 (174,614), Trust 2 (1,134,989), Point Sur LP (228,470) and Point Sur Investors, LLC (252,320), showing continued indirect ownership.
Negative
  • Multiple share disposals: Disposition of 40,000 shares on 01/28/2025 and three disposals of 10,000 each on 01/31/2025 reduced direct holdings.
  • Potential dilution: The 1,246,989 option award at $1.53 strike could materially increase outstanding shares if exercised.
  • Beneficial ownership disclaimers: Reporting person disclaims Section 16 beneficial ownership of shares held in Trust 1 and Trust 2, which may complicate assessments of true control.

Insights

TL;DR: Insider transferred shares to family and disclaims certain trust holdings, while retaining substantial indirect ownership.

The Form 4 shows multiple gift/disposition events in late January 2025 that reduce direct holdings to 643,027 shares. Footnotes explicitly state significant indirect positions held via Trust 1, Trust 2, Point Sur LP and Point Sur Investors, LLC, with explicit disclaimers of Section 16 beneficial ownership for the trust-held shares. For governance and disclosure purposes, the mix of direct disposals and large indirect holdings requires clear investor disclosure; the filing provides the explicit holdings and disclaimers but no additional context on intent.

TL;DR: A large option award was granted, creating long-term incentive but also potential equity dilution.

The reporting person received 1,246,989 stock options on 08/11/2025 at a $1.53 exercise price. The award vests in 16 substantially equal quarterly installments beginning 08/08/2025 and fully vests 08/08/2029, with an expiration date of 08/10/2035. This is a material compensation event: it aligns pay with long-term equity performance but represents a sizable potential issuance of common shares if exercised, which investors should quantify against the company's outstanding share count.

Rainer M. Erdtmann, direttore e dirigente di Biomea Fusion (BMEA), ha segnalato più trasferimenti di azioni alla fine di gennaio 2025 e una consistente assegnazione di opzioni. Il 01/28/2025 ha ceduto 40,000 azioni e il 01/31/2025 ha registrato tre ulteriori cessioni da 10,000 ciascuna insieme a tre acquisizioni indirette da 10,000 azioni attribuite ai suoi figli, mantenendo 643,027 azioni detenute direttamente dopo tali operazioni.

La comunicazione indica partecipazioni indirette in Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) e Point Sur Investors, LLC (252,320). Riporta inoltre l'assegnazione di 1,246,989 opzioni azionarie il 08/11/2025 con prezzo di esercizio di $1.53, che maturano in 16 tranche trimestrali a partire dal 08/08/2025, con piena maturazione il 08/08/2029 e scadenza il 08/10/2035.

Rainer M. Erdtmann, director y directivo de Biomea Fusion (BMEA), informó varias transferencias de acciones a finales de enero de 2025 y una importante concesión de opciones. El 01/28/2025 enajenó 40,000 acciones y el 01/31/2025 registró tres cesiones adicionales de 10,000 cada una junto con tres adquisiciones indirectas de 10,000 atribuidas a sus hijos, quedando con 643,027 acciones en propiedad directa tras esas operaciones.

El informe revela participaciones indirectas en Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) y Point Sur Investors, LLC (252,320). También informa la concesión de 1,246,989 opciones sobre acciones el 08/11/2025 con precio de ejercicio de $1.53, que se consolidan en 16 cuotas trimestrales a partir del 08/08/2025, con consolidación completa el 08/08/2029 y vencimiento el 08/10/2035.

Rainer M. Erdtmann은 Biomea Fusion(BMEA)의 이사이자 임원으로서 2025년 1월 말 여러 차례의 주식 이전과 대규모 스톡옵션 부여를 신고했습니다. 01/28/2025에 40,000주를 처분했으며 01/31/2025에는 각각 10,000주씩 세 건의 추가 처분과 자녀들에게 귀속된 간접 취득 10,000주 세 건을 기록해, 이들 거래 이후 직접 보유 주식은 643,027주입니다.

신고서에는 Trust 1(174,614), Trust 2(1,134,989), Point Sur Investors Fund I, LP(228,470) 및 Point Sur Investors, LLC(252,320)에 대한 간접 보유가 공개되어 있습니다. 또한 08/11/2025에 행사 가격 $1.531,246,989주의 스톡옵션이 부여되었으며, 이는 08/08/2025부터 16회 분기별 베스팅을 거쳐 08/08/2029에 완전히 베스팅되고 만료일은 08/10/2035입니다.

Rainer M. Erdtmann, directeur et cadre de Biomea Fusion (BMEA), a déclaré plusieurs transferts d'actions fin janvier 2025 ainsi qu'une importante attribution d'options. Le 01/28/2025 il a cédé 40,000 actions et le 01/31/2025 a enregistré trois cessions supplémentaires de 10,000 chacune, accompagnées de trois acquisitions indirectes de 10,000 actions attribuées à ses enfants, conservant 643,027 actions détenues directement après ces transactions.

Le dépôt fait état de participations indirectes détenues dans Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) et Point Sur Investors, LLC (252,320). Il signale également l'octroi de 1,246,989 options sur actions le 08/11/2025 au prix d'exercice de $1.53, se vestant en 16 tranches trimestrielles à partir du 08/08/2025, vesting complet le 08/08/2029 et expiration le 08/10/2035.

Rainer M. Erdtmann, ein Direktor und leitender Angestellter von Biomea Fusion (BMEA), meldete mehrere Aktienübertragungen Ende Januar 2025 sowie eine umfangreiche Optionszuteilung. Am 01/28/2025 veräußerte er 40,000 Aktien, und am 01/31/2025 wurden drei weitere Veräußerungen zu je 10,000 sowie drei indirekte Erwerbe zu je 10,000 Aktien, zugeschrieben seinen Kindern, verbucht; nach diesen Transaktionen hielt er direkt 643,027 Aktien.

Die Meldung nennt indirekte Bestände in Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) und Point Sur Investors, LLC (252,320). Ferner wird die Gewährung von 1,246,989 Aktienoptionen am 08/11/2025 mit einem Ausübungspreis von $1.53 berichtet, die in 16 vierteljährlichen Tranchen ab 08/08/2025 vesten, vollständig am 08/08/2029 vesten und am 08/10/2035 verfallen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Erdtmann Rainer M

(Last) (First) (Middle)
C/O BIOMEA FUSION, INC.
1599 INDUSTRIAL ROAD

(Street)
SAN CARLOS CA 94070

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Biomea Fusion, Inc. [ BMEA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
01/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/28/2025 G 40,000 D $0 673,027 D
Common Stock 01/31/2025 G 10,000 D $0 663,027 D
Common Stock 01/31/2025 G 10,000 A $0 19,400 I By daughter
Common Stock 01/31/2025 G 10,000 D $0 653,027 D
Common Stock 01/31/2025 G 10,000 A $0 20,000 I By son
Common Stock 01/31/2025 G 10,000 D $0 643,027 D
Common Stock 01/31/2025 G 10,000 A $0 20,000 I By daughter
Common Stock 174,614 I See Footnote(1)
Common Stock 1,134,989 I See Footnote(2)
Common Stock 228,470 I See Footnote(3)
Common Stock 252,320 I See Footnote(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $1.53 08/11/2025 A 1,246,989 (5) 08/10/2035 Common Stock 1,246,989 $0 1,246,989 D
Explanation of Responses:
1. The shares are held by a trust having an independent trustee ("Trust 1"). The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
2. The shares are held by a trust having an independent trustee ("Trust 2"). The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
3. The shares are held directly by Point Sur Investors Fund I, LP ("Point Sur LP"). The General Partner of Point Sur LP is Point Sur Investors LLC. The Reporting Person is a managing member of Point Sur Investors, LLC and as such has voting and dispositive power over the securities held by Point Sur LP. The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
4. The shares are held directly by Point Sur Investors, LLC. The Reporting Person is a managing members of Point Sur Investors, LLC and as such has voting and dispositive power over the securities held by Point Sur Investors, LLC. The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
5. The option shall vest and become exercisable in 16 substantially equal quarterly installments after August 8, 2025, such that the award will be fully vested and exercisable on August 8, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Remarks:
President, Chief Operating Officer, Principal Financial Officer, and Principal Accounting Officer
/s/ Rainer M. Erdtmann 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the BMEA Form 4 filed by Rainer M. Erdtmann disclose?

The form discloses late-January 2025 share transfers (including a 40,000 share disposition on 01/28/2025 and multiple 10,000 disposals on 01/31/2025), indirect transfers to his children, indirect holdings in trusts and entities, and a 1,246,989 option grant on 08/11/2025.

How many stock options was Erdtmann granted and what are the terms?

He was granted 1,246,989 options on 08/11/2025 at a $1.53 exercise price, vesting in 16 quarterly installments beginning 08/08/2025, fully vesting 08/08/2029, expiring 08/10/2035.

How many shares does Erdtmann directly own after the reported transactions?

Following the reported January 2025 transactions, the filing shows 643,027 shares held directly by the reporting person.

Which indirect holdings are disclosed on the Form 4?

Footnotes disclose indirect holdings: Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470), and Point Sur Investors, LLC (252,320), with disclaimers of Section 16 ownership for the trusts.

Were any transfers made to family members?

Yes. On 01/31/2025 the filing shows indirect acquisitions of 10,000 shares attributed to a daughter, 10,000 to a son, and another 10,000 to a daughter.

Does the reporting person disclaim beneficial ownership of certain shares?

Yes. The footnotes state the reporting person disclaims Section 16 beneficial ownership of shares held by Trust 1 and Trust 2, except to the extent of any pecuniary interest.
Biomea Fusion, Inc.

NASDAQ:BMEA

BMEA Rankings

BMEA Latest News

BMEA Latest SEC Filings

BMEA Stock Data

98.19M
53.83M
9.96%
44.7%
14.61%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN CARLOS